Economics of pediatric burns

Michael J Bass1, Linda G Phillips

  • 1Division of Plastic Surgery, Department of Surgery, 6.124 McCullough Bldg, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA. mjbass@utmb.edu

Insights

Pediatric burn care efficiency is critical. Research is needed to address economic data gaps and reduce costs for better survival and recovery outcomes.

Area of Science:

  • Pediatric burn care
  • Health economics
  • Medical cost-effectiveness

Background:

  • Pediatric burn injuries cause significant physical and psychological distress for children and parents.
  • Common causes include scalds, fire, chemicals, electrical sources, and radiation.
  • Efficient delivery of pediatric burn care is essential for optimizing resource utilization.

Purpose of the Study:

  • To highlight the critical need for economic data in pediatric burn care.
  • To identify areas of inefficiency in current therapeutic modalities.
  • To encourage further research into cost-effective treatments.

Main Methods:

  • Review of existing studies on pediatric burn treatment costs and outcomes.
  • Analysis of cost-effectiveness of different burn treatment modalities.
  • Identification of economic data gaps in pediatric burn research.

Main Results:

  • Scald burns cost approximately $1061 per percent of body surface area burned.
  • Silver-impregnated gauze may reduce costs and hospital stay for superficial burns.
  • Cultured epithelial autografts improve cosmetic outcomes but increase costs.
  • Pediatric burn units treating larger burns or performing surgery can generate revenue.

Conclusions:

  • There is a significant lack of economic data for pediatric burn care.
  • Further research is required to address inefficiencies and improve cost-effectiveness.
  • Increased knowledge of healthcare costs can drive competition and reduce expenditures.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...